(Q43993078)

28 November 2017

title

Angiotensin-II receptor antagonist losartan reduces microalbuminuria in hypertensive renal transplant recipients (English)

1 reference

28 November 2017

1 reference

Alparslan Ersoy

1

1 reference

28 November 2017

Kamil Dilek

2

1 reference

28 November 2017

Mehmet Usta

3

1 reference

28 November 2017

Mahmut Yavuz

4

1 reference

28 November 2017

Mustafa Güllülü

5

1 reference

28 November 2017

Bülent Oktay

6

1 reference

28 November 2017

Mustafa Yurtkuran

7

1 reference

28 November 2017

publication date

1 June 2002

1 reference

28 November 2017

published in

Clinical Transplantation

1 reference

28 November 2017

volume

16

1 reference

28 November 2017

issue

3

1 reference

28 November 2017

page(s)

202-205

1 reference

Evaluation of kidney function in renal transplant patients receiving long-term cyclosporine

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.01127.X

Cross sectional longitudinal study of spot morning urine protein:creatinine ratio, 24 hour urine protein excretion rate, glomerular filtration rate, and end stage renal failure in chronic renal disease in patients without diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.01127.X

The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.01127.X

Microalbuminuria in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.01127.X

Angiotensin II receptor antagonists and treatment of hypertension and renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.01127.X

Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.01127.X

7 January 2021

The prognostic importance of severity and type of post-transplant proteinuria

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.01127.X

7 January 2021

Long-term anti-proteinuric effect of Losartan in renal transplant recipients treated for hypertension

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.01127.X

7 January 2021

Is microalbuminuria a predictor of cardiovascular and renal disease in patients with essential hypertension?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.01127.X

7 January 2021

Microalbuminuria in Hypertension

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.01127.X

7 January 2021

Progressive albuminuria and glomerulosclerosis in a rat model of chronic renal allograft rejection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.01127.X

7 January 2021

ACE inhibitors and angiotensin II antagonists in renal transplantation: an analysis of safety and efficacy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.01127.X

7 January 2021

Angiotensin II blockade decreases TGF-beta1 and matrix proteins in cyclosporine nephropathy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.01127.X

7 January 2021

10.1034/J.1399-0012.2002.01127.X

Identifiers

DOI

1 reference

28 November 2017

1 reference